Stopping aspirin after one month of dual therapy after heart attack
Treatments studied
Part of Heart & circulation clinical trials.
This study looks at whether stopping aspirin after a month of dual antiplatelet therapy (aspirin plus clopidogrel) is safe and effective for people who had a heart attack and received stents. It compares staying on aspirin long-term versus switching to only clopidogrel to prevent future heart problems while lowering bleeding risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You've had a recent heart attack or unstable angina (like sudden chest pain at rest).
- You received a stent and took two blood thinners (aspirin plus clopidogrel) for about a month without any bleeding or other problems.
- All significant blockages in your heart arteries were opened during the stent procedure.
- You are not already taking a blood thinner for another condition (like atrial fibrillation or blood clots).
- You have no history of serious bleeding or bleeding disorders.
- Your kidney function and heart pumping are not severely reduced.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if it is safe to stop taking daily aspirin after a heart attack and a stent procedure, compared to continuing it. It aims to help older adults avoid unnecessary bleeding while preventing another heart attack or stroke.
This study looks at whether taking a second blood thinner (clopidogrel) plus aspirin for a longer time helps prevent heart problems after a stent opens a fully blocked artery. It compares two durations of treatment to see which is better for patients like you.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial studies whether changing the timing and type of blood-thinner tablets after a heart stent is as safe and effective as continuing the same plan. It may help some people by simplifying treatment while preventing dangerous clotting after a coronary procedure.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
Hear when a new Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.